Investigative Ophthalmology & Visual Science, Vol 23, 516-524, Copyright © 1982 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Spectral sensitivity and color discrimination changes in glaucoma and glaucoma-suspect patients

AJ Adams, R Rodic, R Husted and R Stamper

Color vision changes may occur early in the course of glaucoma and may precede visual field loss. Glaucoma suspects, having raised intraocular pressure and no diagnostic optic nerve head or visual field changes, may also have color vision loss. Unfortunately, the instruments used in the studies that have demonstrated these color vision changes were not feasible for routine clinical use; likewise, the studies did not carefully control for the effects of small pupil size and age or did not point to the underlying mechanisms responsible. We studied 19 glaucoma patients, 19 glaucoma suspects, and age-matched controls for each group by means of the Farnsworth D-15 panel test, a desaturated version of the D-15 test, and by measures of spectral increment threshold. Minor modifications of the Farnsworth D-15 panel test produce highly significant differentiation of glaucoma and glaucoma- suspect patients from age-matched normal groups. Further, spectral increment thresholds, with a two-degree spectral target flashed at either 1 or 25 Hz on a bright white background, show that both achromatic and chromatic sensitivity are significantly reduced when compared with their age-matched normals. Pupil size does not seem to be a significant factor. These results suggest that the function of two different ganglion cell populations is affected in glaucoma and that glaucoma may produce functional loss in the central foveal area earlier in the disease process than previously believed.

This article has been cited by other articles:

				A. Eisner, M. D. Toomey, L. J. Incognito, J. P. O'Malley, and J. R. Samples Contrasting Blue-on-Yellow with White-on-White Visual Fields: Roles of Visual Adaptation for Healthy Peri- or Postmenopausal Women Younger Than 70 Years of Age Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5605 - 5614. [Abstract] [Full Text] [PDF]

				M. Castelo-Branco, P. Faria, V. Forjaz, L. R. Kozak, and H. Azevedo Simultaneous Comparison of Relative Damage to Chromatic Pathways in Ocular Hypertension and Glaucoma: Correlation with Clinical Measures Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 499 - 505. [Abstract] [Full Text] [PDF]

				A Eisner, D F Austin, and J R Samples Short wavelength automated perimetry and tamoxifen use Br. J. Ophthalmol., January 1, 2004; 88(1): 125 - 130. [Abstract] [Full Text] [PDF]

				F. K. Horn, J. B. Jonas, W. M. Budde, A. M. Junemann, C. Y. Mardin, and M. Korth Monitoring Glaucoma Progression with Visual Evoked Potentials of the Blue-Sensitive Pathway Invest. Ophthalmol. Vis. Sci., June 1, 2002; 43(6): 1828 - 1834. [Abstract] [Full Text] [PDF]

				M PACHECO-CUTILLAS, D F EDGAR, and A SAHRAIE Acquired colour vision defects in glaucoma---their detection and clinical significance Br. J. Ophthalmol., December 1, 1999; 83(12): 1396 - 1402. [Full Text] [PDF]